We are live on ! Find out more
GHCM

Glen Harbor Capital Management Portfolio holdings

AUM $4.82B
1-Year Est. Return 4.69%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+4.69%
3 Year Est. Return
+49.45%
5 Year Est. Return
10 Year Est. Return
AUM
$4.79B
AUM Growth
+$135M
Cap. Flow
-$11.3M
Cap. Flow %
-0.24%
Top 10 Hldgs %
21.63%
Holding
1,353
New
51
Increased
493
Reduced
318
Closed
30

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$28.9M
2
CELG
Celgene Corp
CELG
+$27.8M
3
INTC icon
Intel
INTC
+$19.4M
4
PYPL icon
PayPal
PYPL
+$11.3M
5
NKE icon
Nike
NKE
+$11.1M

Sector Composition

Rank Sector Weight
1 Technology 17.75%
2 Financials 15.97%
3 Healthcare 12.71%
4 Consumer Discretionary 10.41%
5 Industrials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
1301
Heron Therapeutics
HRTX
$59.6M
$18K ﹤0.01%
+946
New +$18.9K
IOVA icon
1302
Iovance Biotherapeutics
IOVA
$4.24B
$18K ﹤0.01%
752
ALTR
1303
DELISTED
Altair Engineering Inc
ALTR
$18K ﹤0.01%
440
ECOM
1304
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$18K ﹤0.01%
2,006
MAT icon
1305
Mattel
MAT
$3.83B
$17K ﹤0.01%
1,540
-28,182
-95% -$331K
SSTI icon
1306
SoundThinking
SSTI
$77.9M
$17K ﹤0.01%
374
-1,870
-83% -$87.5K
DNLI icon
1307
Denali Therapeutics
DNLI
$3.26B
$16K ﹤0.01%
756
TRQ
1308
DELISTED
Turquoise Hill Resources Ltd
TRQ
$16K ﹤0.01%
1,319
+85
+7% +$1.18K
UPLD icon
1309
Upland Software
UPLD
$11.1M
$15K ﹤0.01%
32
AKRO
1310
DELISTED
Akero Therapeutics
AKRO
$14K ﹤0.01%
+748
New +$14.2K
NTNX icon
1311
Nutanix
NTNX
$18.4B
$12K ﹤0.01%
462
-990
-68% -$34.5K
CSOD
1312
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$12K ﹤0.01%
208
ALEC icon
1313
Alector
ALEC
$227M
$11K ﹤0.01%
560
REPL icon
1314
Replimune Group
REPL
$1.23B
$10K ﹤0.01%
656
VCIT icon
1315
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.7B
$8K ﹤0.01%
88
XLI icon
1316
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
$7K ﹤0.01%
96
-272
-74% -$20.7K
CHMA
1317
DELISTED
Chiasma, Inc. Common Stock
CHMA
$6K ﹤0.01%
816
+80
+11% +$525
CRNX
1318
DELISTED
Crinetics Pharmaceuticals
CRNX
$5K ﹤0.01%
220
ESTC icon
1319
Elastic
ESTC
$8.94B
$5K ﹤0.01%
64
-160
-71% -$13.1K
BPY
1320
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$3K ﹤0.01%
160
ALNA
1321
DELISTED
Allena Pharmaceuticals
ALNA
$2K ﹤0.01%
464
ARD
1322
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$2K ﹤0.01%
+102
New +$1.49K
ALV icon
1323
Autoliv
ALV
$8.51B
-1,292
Closed -$95K
ASMB icon
1324
Assembly Biosciences
ASMB
$532M
-40
Closed -$9K
BIDU icon
1325
Baidu
BIDU
$30.8B
-1,360
Closed -$224K

Similar funds

Glen Harbor Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Glen Harbor Capital Management held 1,353 positions worth $4.79B, up 2.9% from $4.65B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Glen Harbor Capital Management's Q2 2019 filing shows 51 new, 493 increased, 318 reduced and 30 closed positions. Its largest new stake was Middleby: 9,688 shares worth $1.31M. The largest sale was Linde, an estimated $28.9M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Glen Harbor Capital Management's largest Q2 2019 buy was Middleby: 9,688 shares worth $1.31M.
  • Glen Harbor Capital Management added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $22.9M increase.
  • Glen Harbor Capital Management's biggest Q2 2019 reduction was Linde, cutting an estimated $28.9M.
  • Glen Harbor Capital Management fully exited Burlington in Q2 2019, selling an estimated $1.56M.
  • Glen Harbor Capital Management's ten largest holdings make up 22% of its $4.79B portfolio in Q2 2019.
  • Glen Harbor Capital Management opened 51 new positions and closed 30 in Q2 2019.
  • Glen Harbor Capital Management's portfolio value rose 2.9% quarter-over-quarter to $4.79B.

Based on Glen Harbor Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.